Zosano Pharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more

Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Founded:

2006

Status:

PublicNASDAQZSAN

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Biohaven has been one of Zosano Pharma's top competitors. Biohaven's headquarters is in New Haven, Connecticut, and was founded in 2013. Like Zosano Pharma, Biohaven also competes in the Pharmaceuticals field. Biohaven generates 10,208% of Zosano Pharma's revenue.

Alder BioPharmaceuticals is one of Zosano Pharma's top rivals. Alder BioPharmaceuticals is a Private company that was founded in Bothell, Washington in 2004. Like Zosano Pharma, Alder BioPharmaceuticals also works within the Pharmaceuticals industry. Alder BioPharmaceuticals has 149 more employees vs. Zosano Pharma.

Corium is perceived as one of Zosano Pharma's biggest rivals. Corium was founded in 1995, and is headquartered in Menlo Park, California. Like Zosano Pharma, Corium also competes in the Pharmaceuticals sector. Corium generates $36.1M more revenue vs. Zosano Pharma.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Zosano Pharma?

Quarterly and Annual Revenue

Coming soon for Zosano Pharma!

Annual Revenue

$ < 1M

Zosano Pharma's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 11M.

Acquisitions

No recent acquisitions found related to Zosano Pharma

Zosano Pharma Funding History

$90M$120M$123M$126.9M$206.4M$213.9M$215.5M

Since Zosano Pharma was founded in 2006, it has participated in 10 rounds of funding. In total Zosano Pharma has raised $215.5M. Zosano Pharma's last funding round was on Apr 2020 for a total of $1.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$1.6M

Silicon Valley Bank

Equity
Aug 2016
$7.5M
-
Debt
Jun 2015
$15M
Equity
Jan 2015
$15M
-
IPO
Jan 2015
$49.5M

Total Funding: $215.5M

Since Zosano Pharma was founded in 2006, it has participated in 10 rounds of funding. In total Zosano Pharma has raised $215.5M. Zosano Pharma's last funding round was on Apr 2020 for a total of $1.6M

Investments

No recent investments found related to Zosano Pharma

Zosano Pharma News

August 18, 2020Benzinga

Why Zosano Pharma's Stock Is Trading Higher Today

Zosano Pharma (NASDAQ: ZSAN) shares are trading higher on Tuesday after the company announced an agre... See more »
August 2, 2020Benzinga

Zosano Pharma to Present at the BTIG Biotechnology Conference 2020

FREMONT, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
June 15, 2020Market Exclusive

ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN) Files An 8-K Other Events

On June 13, 2020, Zosano Pharma Corporation (the “Company”) announced that new post-hoc efficacy anal... See more »
June 9, 2020Market Exclusive

ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN) Files An 8-K Entry into a Material Definitive Agreement

ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN) Files An 8-K Entry into a Material Definitive Agreement Item ... See more »
May 14, 2020ForexTV

Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update

FREMONT, Calif., May 14, 2020 (GLOBE NEWSWIRE) - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-... See more »

Zosano Pharma Press Releases

February 21, 2019GlobeNewswire

Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta for the Acute Treatment of Migraine Disease

FREMONT, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
May 8, 2018StreetInsider

Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update

Zosano Pharma Corporation (NASDAQ: ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutic... See more »
October 21, 2017streetinsider

Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital

FREMONT, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN) (“Zosano”... See more »
October 20, 2017econotimes

Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital

Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutica... See more »
August 2, 2017GlobeNewswire

Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update

FREMONT, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
June 13, 2017econotimes

Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage biopharmaceutical company focused on provid... See more »

Headquarters

34790 Ardentech Court

Fremont, California94555

510-745-1200

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Zosano Pharma was founded in 2006. Zosano Pharma's headquarters is located in Fremont, California, USA 9455...

CEO

Zosano Pharma's President & CEO, Steven Lo, currently has an approval rating of 83%. Zosano Pharma's primary competitors are Biohaven, Alder BioPharmaceuticals & Corium.

Website

zosanopharma.com

Frequently Asked Questions about Zosano Pharma

  1. When was Zosano Pharma founded?

    Zosano Pharma was founded in 2006
  2. Who is Zosano Pharma's CEO?

    Zosano Pharma's CEO is Steven Lo
  3. How much revenue does Zosano Pharma generate?

    Zosano Pharma generates $ < 1M in revenue
  4. How much funding does Zosano Pharma have?

    Zosano Pharma has historically raised $215.5M in funding
  1. Where is Zosano Pharma's headquarters?

    Zosano Pharma's headquarters is in Fremont California, USA
  2. How many employees does Zosano Pharma have?

    Zosano Pharma has 53 employees
  3. What sector does Zosano Pharma operate in?

    Zosano Pharma is in Pharmaceuticals
  4. Who are Zosano Pharma's competitors?

    Zosano Pharma's top competitors are Biohaven, Alder BioPharmaceuticals, Corium